Table 5. Laboratory Findings of Patients Infected with SARS-CoV-2 according to age.
|
All patients (n=50) |
Age<60 years (n=37) |
Age≥60 years (n=13) |
pa | |
| Blood routine, median (range) | ||||
| Leucocytes (× 103 per µl); normal range: 3·5–9 | 5.80 (2.40-9.80) | 6.1 (2.4-9.8) | 5.7 (3.0-9.0) | 0.67 |
| Neutrophils (%); normal range: 40-70 | 72.20 (48.2-86.7) | 69.95 (48.7-86.7) | 73.0 (48.2-83.8) | 0.58 |
| Lymphocytes (%); normal range: 20-50 | 19.10 (7.3-42.0) | 21.65 (7.3-42) | 18.7 (8.8-40.4) | 0.44 |
| Platelets (× 103 per µl); normal range: 150–450 | 176 (100-436) | 181.5 (105-390) | 164 (100-436) | 0.17 |
| Hemoglobin (g/dl); normal range: 13.5-18 | 12.5 (3.2-18.1) | 12.8 (3.2-18.1) | 11.5 (7.9-15.7) | 0.15 |
| Coagulation function | ||||
| Prothrombin time (s); normal range: 12-14 | 13.20 (12-15.3) | 13.2 (12-14.5) | 13.1 (12.1-15.3) | 0.76 |
| partial thromboplastin time (s); normal range: 25-45 | 33(25-64) | 33 (25-39) | 31.8 (28-64) | 0.94 |
| International Normalized Ratio (S) | 1.10 (1-1.40) | 1.10 (1.00-1.34) | 1.1 (1.00-1.40) | 0.77 |
| Blood biochemistry, median (range) | ||||
| Alanine aminotransferase (U/L); normal range :up to 41 | 31 (15-237) | 31 (18-92) | 33.5 (15-237) | 0.68 |
| Aspartate aminotransferase (U/L); normal range: up to 37 | 36 (14-203) | 31.5 (14-77) | 48.5 (33-203) | 0.019 |
| Alkaline phosphatase (U/L); normal range: 98- 279 | 157 (59-273) | 157.5 (85-273) | 146 (59-251) | 0.64 |
| Total bilirubin (mg/dl); normal range: 0.1–1.2 | 0.8 (0.4-3.3) | 0.75 (0.4-2.6) | 0.8 (0.5-3.3) | 0.91 |
| Serum creatinine (mg/dl); normal range: 0.6-1.3 | 0.90 (0.6-5.6) | 0.9 (0.6-1.7) | 1.0 (0.7-5.6) | 0.08 |
| Urea( mg/dl); normal range: 11-55 | 34 (13-128) | 30 (13-64) | 39 (29-128) | 0.005 |
| Lactate dehydrogenase (U/L); normal range: 120–460 | 476.50 (284-1247) | 443 (284-1247) | 540 (340-820) | 0.042 |
| Glucose (mg/dl); normal range <140 | 95 (71-409) | 91 (71-409) | 99 (79-324) | 0.63 |
| Albumin(gr/dl); normal range: 3.5-5 (n=3) | 4 (3.7-4.1) | 4.0 (3.7-4.1) | - | - |
| Troponin I (ng/l); normal range<19 (n=10) | 5.2 (1.20-29.20) | 3.4 (1.2-23.1) | 7.9 (5-29.2) | 0.18 |
| Creatine phosphokinase (CPK) (mg/dl); normal range: 24-195 (n=5) | 163 (58-501) | 119.5 (58-501) | 225 | 0.80 |
| Ferritin (ng/ml); normal range: 4.63-204 (n=8) | 589.85 (87.99-2560) | 589.9 (88.0-1403.9) | 1505.4 (450.8-2560) | 0.51 |
| PH; normal range: 7.35-7.45 (n=13) | 7.44 (7.32-7.50) | 7.45 (7.40-7.50) | 7.44 (7.32-7.49) | 0.94 |
| HCO3- (mmol/l); normal range: 24 (n=13) | 23.20 (16.80-30.5) | 25 (21.6-30.5) | 23 (16.8-25.9) | 0.28 |
| Infection-related biomarkers | ||||
| Erythrocyte sedimentation rate (mm/h); normal range: 0·0–15·0 | 38 (4-108) | 34 (4-85) | 38 (15-108) | 0.29 |
| C-reactive protein (qualitative); normal range: 0 | 2.50 (0-3) | 2 (0-3) | 3 (0-3) | 0.65 |
a. P values indicate differences between age<60 years and Age≥60 years patients. P < .05 was considered statistically significant.